About us
Explore how
Learn more
Read more
Milestone for Biopharmaceuticals in China
As one of the world’s largest biopharmaceutical producers, Boehringer Ingelheim is China’s first international provider of biopharmaceutical contract manufacturing solutions with all-round services, including process development and product supply for clinical trials and market, to its clients in China and all over the world.
Boehringer Ingelheim started to become involved in a reform of the Chinese MAH/Contract Manufacturing model in 2014, which enables a new regulatory pathway to authorize a third party in manufacturing biopharmaceutical products for drug authorization holders.
Now Boehringer Ingelheim BioXcellence™ manufactures the first biopharmaceutical approved in China under new MAH contract manufacturing regulatory system.
Our Business
Boehringer Ingelheim BioXcellence™ offers reliable world-class biopharmaceuticals contract development and manufacturing services to the pharmaceutical and biotechnology industry.
Global Network
Our network of manufacturing facilities spans the globe, from Biberach in Germany, to Vienna in Austria, Fremont, California in the United States and Shanghai in China. From these sites we offer our customers first class biopharmaceutical medicines anywhere in the world.
Contact Us
Boehringer Ingelheim BioXcellence™ welcomes your inquiries, questions and feedback.